25 XP   0   0   10

Cyberdyne Inc ADR
Buy, Hold or Sell?

Let's analyse Cyberdyne together

PenkeI guess you are interested in Cyberdyne Inc ADR. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Cyberdyne Inc ADR. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Cyberdyne Inc ADR

I send you an email if I find something interesting about Cyberdyne Inc ADR.

Quick analysis of Cyberdyne (30 sec.)










What can you expect buying and holding a share of Cyberdyne? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$1.24
Expected worth in 1 year
$1.19
How sure are you?
27.5%

+ What do you gain per year?

Total Gains per Share
$-0.05
Return On Investment
-4.4%

For what price can you sell your share?

Current Price per Share
$1.23
Expected price per share
$1.23 - $1.3
How sure are you?
50%

1. Valuation of Cyberdyne (5 min.)




Live pricePrice per Share (EOD)

$1.23

Intrinsic Value Per Share

$-0.14 - $-0.15

Total Value Per Share

$1.10 - $1.10

2. Growth of Cyberdyne (5 min.)




Is Cyberdyne growing?

Current yearPrevious yearGrowGrow %
How rich?$262.3m$279.7m-$12.8m-4.8%

How much money is Cyberdyne making?

Current yearPrevious yearGrowGrow %
Making money-$2.1m$260.8k-$2.3m-112.4%
Net Profit Margin-32.0%5.8%--

How much money comes from the company's main activities?

3. Financial Health of Cyberdyne (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#91 / 334

Most Revenue
#203 / 334

Most Profit
#181 / 334

Most Efficient
#192 / 334

What can you expect buying and holding a share of Cyberdyne? (5 min.)

Welcome investor! Cyberdyne's management wants to use your money to grow the business. In return you get a share of Cyberdyne.

What can you expect buying and holding a share of Cyberdyne?

First you should know what it really means to hold a share of Cyberdyne. And how you can make/lose money.

Speculation

The Price per Share of Cyberdyne is $1.23. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Cyberdyne.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Cyberdyne, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.24. Based on the TTM, the Book Value Change Per Share is $-0.01 per quarter. Based on the YOY, the Book Value Change Per Share is $0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Cyberdyne.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.01-0.9%0.00-0.4%0.000.1%0.00-0.2%0.00-0.3%
Usd Book Value Change Per Share-0.01-1.1%-0.01-1.1%0.000.3%0.00-0.4%0.032.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.01-1.1%-0.01-1.1%0.000.3%0.00-0.4%0.032.5%
Usd Price Per Share1.50-1.92-2.42-3.86-4.96-
Price to Earnings Ratio-35.45-14.69-222.20--25.22--185.23-
Price-to-Total Gains Ratio-107.11--37.80-295.71--184.01--1,333.21-
Price to Book Ratio1.21-1.52-1.86-2.96-3.68-
Price-to-Total Gains Ratio-107.11--37.80-295.71--184.01--1,333.21-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.23
Number of shares813
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.010.00
Usd Total Gains Per Share-0.010.00
Gains per Quarter (813 shares)-10.98-3.94
Gains per Year (813 shares)-43.91-15.77
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-44-540-16-26
20-88-980-32-42
30-132-1420-47-58
40-176-1860-63-74
50-220-2300-79-90
60-263-2740-95-106
70-307-3180-110-122
80-351-3620-126-138
90-395-4060-142-154
100-439-4500-158-170

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.02.00.050.0%5.07.00.041.7%8.012.00.040.0%9.031.00.022.5%9.031.00.022.5%
Book Value Change Per Share1.03.00.025.0%4.08.00.033.3%7.013.00.035.0%11.029.00.027.5%11.029.00.027.5%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.040.00.0%
Total Gains per Share1.03.00.025.0%4.08.00.033.3%7.013.00.035.0%11.029.00.027.5%11.029.00.027.5%

Fundamentals of Cyberdyne

About Cyberdyne Inc ADR

CYBERDYNE Inc. researches, develops, produces, sell, leases, and maintains equipment and systems for medical and warfare in Japan. The company offers Hybrid Assistive Limb (HAL) for medical use in lower limb and single joint type; non-medical HAL for lower limb, single joint type, and lumbar type; HAL peripherals; cleaning robots; transportation robots for various transportation tasks in factories, offices, and other indoor environments; and Acoustic X, a high-speed light pulse LED array light source that enables real time photoacoustic imaging. It also provides Cybernics Treatment, a treatment that uses HAL to enhance and regenerate the function of the wearer for spinal cord injury, stroke, neuromuscular diseases, etc.; Neuro HALFIT for enhancement of brain-nerve-musculoskeltal system; MTX Neuro HAL Plus to enhance the performance of the athletes' brain-nerve functions; and Neuro HALFIT at home for enhancement of physical functions. In addition, the company is involved in the provision of rescue supports in disaster sites, and heavy labor supports for factories and plants, as well as entertainment business. The company was incorporated in 2004 and is headquartered in Tsukuba, Japan.

Fundamental data was last updated by Penke on 2024-05-16 00:02:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Cyberdyne Inc ADR.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Cyberdyne earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Cyberdyne to the Medical Devices industry mean.
  • A Net Profit Margin of -31.3% means that $-0.31 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Cyberdyne Inc ADR:

  • The MRQ is -31.3%. The company is making a huge loss. -2
  • The TTM is -32.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-31.3%TTM-32.0%+0.7%
TTM-32.0%YOY5.8%-37.8%
TTM-32.0%5Y-18.3%-13.6%
5Y-18.3%10Y-47.5%+29.1%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-31.3%-10.8%-20.5%
TTM-32.0%-17.8%-14.2%
YOY5.8%-13.3%+19.1%
5Y-18.3%-19.6%+1.3%
10Y-47.5%-24.5%-23.0%
1.1.2. Return on Assets

Shows how efficient Cyberdyne is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Cyberdyne to the Medical Devices industry mean.
  • -0.7% Return on Assets means that Cyberdyne generated $-0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Cyberdyne Inc ADR:

  • The MRQ is -0.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -0.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.7%TTM-0.7%0.0%
TTM-0.7%YOY0.1%-0.7%
TTM-0.7%5Y-0.2%-0.4%
5Y-0.2%10Y-0.5%+0.3%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.7%-3.6%+2.9%
TTM-0.7%-4.2%+3.5%
YOY0.1%-3.8%+3.9%
5Y-0.2%-3.7%+3.5%
10Y-0.5%-4.3%+3.8%
1.1.3. Return on Equity

Shows how efficient Cyberdyne is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Cyberdyne to the Medical Devices industry mean.
  • -0.8% Return on Equity means Cyberdyne generated $-0.01 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Cyberdyne Inc ADR:

  • The MRQ is -0.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -0.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.8%TTM-0.8%-0.1%
TTM-0.8%YOY0.1%-0.9%
TTM-0.8%5Y-0.3%-0.5%
5Y-0.3%10Y-0.6%+0.3%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.8%-3.7%+2.9%
TTM-0.8%-4.7%+3.9%
YOY0.1%-4.8%+4.9%
5Y-0.3%-5.6%+5.3%
10Y-0.6%-5.7%+5.1%

1.2. Operating Efficiency of Cyberdyne Inc ADR.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Cyberdyne is operating .

  • Measures how much profit Cyberdyne makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Cyberdyne to the Medical Devices industry mean.
  • An Operating Margin of -30.1% means the company generated $-0.30  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Cyberdyne Inc ADR:

  • The MRQ is -30.1%. The company is operating very inefficient. -2
  • The TTM is -27.6%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-30.1%TTM-27.6%-2.5%
TTM-27.6%YOY3.4%-31.1%
TTM-27.6%5Y-14.6%-13.0%
5Y-14.6%10Y-70.3%+55.7%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-30.1%-28.6%-1.5%
TTM-27.6%-13.8%-13.8%
YOY3.4%-14.5%+17.9%
5Y-14.6%-18.9%+4.3%
10Y-70.3%-24.4%-45.9%
1.2.2. Operating Ratio

Measures how efficient Cyberdyne is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 1.30 means that the operating costs are $1.30 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Cyberdyne Inc ADR:

  • The MRQ is 1.301. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.496. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.301TTM1.496-0.195
TTM1.496YOY1.303+0.194
TTM1.4965Y1.473+0.024
5Y1.47310Y1.865-0.392
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3011.424-0.123
TTM1.4961.431+0.065
YOY1.3031.396-0.093
5Y1.4731.413+0.060
10Y1.8651.375+0.490

1.3. Liquidity of Cyberdyne Inc ADR.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Cyberdyne is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 18.35 means the company has $18.35 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Cyberdyne Inc ADR:

  • The MRQ is 18.355. The company is very able to pay all its short-term debts. +2
  • The TTM is 16.650. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ18.355TTM16.650+1.704
TTM16.650YOY26.216-9.566
TTM16.6505Y40.217-23.566
5Y40.21710Y51.766-11.550
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ18.3552.689+15.666
TTM16.6502.724+13.926
YOY26.2163.418+22.798
5Y40.2173.658+36.559
10Y51.7663.632+48.134
1.3.2. Quick Ratio

Measures if Cyberdyne is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Cyberdyne to the Medical Devices industry mean.
  • A Quick Ratio of 17.20 means the company can pay off $17.20 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Cyberdyne Inc ADR:

  • The MRQ is 17.197. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 21.343. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ17.197TTM21.343-4.145
TTM21.343YOY40.980-19.637
TTM21.3435Y63.700-42.357
5Y63.70010Y77.894-14.194
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ17.1971.494+15.703
TTM21.3431.532+19.811
YOY40.9802.100+38.880
5Y63.7002.336+61.364
10Y77.8942.596+75.298

1.4. Solvency of Cyberdyne Inc ADR.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Cyberdyne assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Cyberdyne to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.19 means that Cyberdyne assets are financed with 18.6% credit (debt) and the remaining percentage (100% - 18.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Cyberdyne Inc ADR:

  • The MRQ is 0.186. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.181. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.186TTM0.181+0.004
TTM0.181YOY0.137+0.044
TTM0.1815Y0.109+0.073
5Y0.10910Y0.128-0.020
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1860.417-0.231
TTM0.1810.401-0.220
YOY0.1370.335-0.198
5Y0.1090.441-0.332
10Y0.1280.454-0.326
1.4.2. Debt to Equity Ratio

Measures if Cyberdyne is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Cyberdyne to the Medical Devices industry mean.
  • A Debt to Equity ratio of 22.7% means that company has $0.23 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Cyberdyne Inc ADR:

  • The MRQ is 0.227. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.221. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.227TTM0.221+0.006
TTM0.221YOY0.159+0.062
TTM0.2215Y0.125+0.096
5Y0.12510Y0.185-0.060
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2270.601-0.374
TTM0.2210.607-0.386
YOY0.1590.487-0.328
5Y0.1250.640-0.515
10Y0.1850.682-0.497

2. Market Valuation of Cyberdyne Inc ADR

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Cyberdyne generates.

  • Above 15 is considered overpriced but always compare Cyberdyne to the Medical Devices industry mean.
  • A PE ratio of -35.45 means the investor is paying $-35.45 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Cyberdyne Inc ADR:

  • The EOD is -29.066. Based on the earnings, the company is expensive. -2
  • The MRQ is -35.447. Based on the earnings, the company is expensive. -2
  • The TTM is 14.693. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD-29.066MRQ-35.447+6.380
MRQ-35.447TTM14.693-50.140
TTM14.693YOY222.201-207.507
TTM14.6935Y-25.221+39.915
5Y-25.22110Y-185.228+160.006
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-29.066-1.143-27.923
MRQ-35.447-1.704-33.743
TTM14.693-2.344+17.037
YOY222.201-2.982+225.183
5Y-25.221-2.449-22.772
10Y-185.228-2.057-183.171
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Cyberdyne Inc ADR:

  • The EOD is -39.319. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -47.949. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -54.353. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-39.319MRQ-47.949+8.631
MRQ-47.949TTM-54.353+6.404
TTM-54.353YOY-22.155-32.198
TTM-54.3535Y-82.015+27.661
5Y-82.01510Y-49.738-32.276
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-39.319-1.960-37.359
MRQ-47.949-3.111-44.838
TTM-54.353-3.078-51.275
YOY-22.155-5.861-16.294
5Y-82.015-5.350-76.665
10Y-49.738-5.716-44.022
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Cyberdyne is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 1.21 means the investor is paying $1.21 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Cyberdyne Inc ADR:

  • The EOD is 0.990. Based on the equity, the company is cheap. +2
  • The MRQ is 1.207. Based on the equity, the company is underpriced. +1
  • The TTM is 1.521. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.990MRQ1.207-0.217
MRQ1.207TTM1.521-0.314
TTM1.521YOY1.858-0.337
TTM1.5215Y2.964-1.443
5Y2.96410Y3.684-0.719
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD0.9902.067-1.077
MRQ1.2072.362-1.155
TTM1.5212.532-1.011
YOY1.8582.943-1.085
5Y2.9644.061-1.097
10Y3.6844.533-0.849
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Cyberdyne Inc ADR compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.014-0.014-4%0.004-484%-0.005-65%0.031-145%
Book Value Per Share--1.2431.259-1%1.301-4%1.297-4%1.165+7%
Current Ratio--18.35516.650+10%26.216-30%40.217-54%51.766-65%
Debt To Asset Ratio--0.1860.181+2%0.137+35%0.109+71%0.128+45%
Debt To Equity Ratio--0.2270.221+3%0.159+43%0.125+81%0.185+23%
Dividend Per Share----0%-0%-0%-0%
Eps---0.011-0.005-55%0.001-971%-0.003-76%-0.004-63%
Free Cash Flow Per Share---0.008-0.010+29%-0.011+38%-0.011+35%-0.010+28%
Free Cash Flow To Equity Per Share---0.009-0.018+89%-0.002-83%-0.005-42%-0.006-41%
Gross Profit Margin--1.4611.300+12%0.555+163%0.971+50%0.986+48%
Intrinsic Value_10Y_max---0.145--------
Intrinsic Value_10Y_min---0.138--------
Intrinsic Value_1Y_max---0.043--------
Intrinsic Value_1Y_min---0.043--------
Intrinsic Value_3Y_max---0.108--------
Intrinsic Value_3Y_min---0.104--------
Intrinsic Value_5Y_max---0.147--------
Intrinsic Value_5Y_min---0.138--------
Market Cap259691139.840-22%316696854.000406781179.490-22%519491808.921-39%830075126.456-62%1062914587.472-70%
Net Profit Margin---0.313-0.320+2%0.058-638%-0.183-41%-0.475+52%
Operating Margin---0.301-0.276-8%0.034-977%-0.146-52%-0.703+133%
Operating Ratio--1.3011.496-13%1.3030%1.473-12%1.865-30%
Pb Ratio0.990-22%1.2071.521-21%1.858-35%2.964-59%3.684-67%
Pe Ratio-29.066+18%-35.44714.693-341%222.201-116%-25.221-29%-185.228+423%
Price Per Share1.230-22%1.5001.918-22%2.417-38%3.864-61%4.962-70%
Price To Free Cash Flow Ratio-39.319+18%-47.949-54.353+13%-22.155-54%-82.015+71%-49.738+4%
Price To Total Gains Ratio-87.829+18%-107.108-37.801-65%295.714-136%-184.013+72%-1333.206+1145%
Quick Ratio--17.19721.343-19%40.980-58%63.700-73%77.894-78%
Return On Assets---0.007-0.007-5%0.001-940%-0.002-65%-0.005-29%
Return On Equity---0.008-0.008-6%0.001-1012%-0.003-67%-0.006-32%
Total Gains Per Share---0.014-0.014-4%0.004-484%-0.005-65%0.031-145%
Usd Book Value--262380800.000266894400.000-2%279726400.000-6%278253120.000-6%249386090.720+5%
Usd Book Value Change Per Share---0.014-0.014-4%0.004-484%-0.005-65%0.031-145%
Usd Book Value Per Share--1.2431.259-1%1.301-4%1.297-4%1.165+7%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.011-0.005-55%0.001-971%-0.003-76%-0.004-63%
Usd Free Cash Flow---1651200.000-2142400.000+30%-2323200.000+41%-2265920.000+37%-1452320.000-12%
Usd Free Cash Flow Per Share---0.008-0.010+29%-0.011+38%-0.011+35%-0.010+28%
Usd Free Cash Flow To Equity Per Share---0.009-0.018+89%-0.002-83%-0.005-42%-0.006-41%
Usd Market Cap259691139.840-22%316696854.000406781179.490-22%519491808.921-39%830075126.456-62%1062914587.472-70%
Usd Price Per Share1.230-22%1.5001.918-22%2.417-38%3.864-61%4.962-70%
Usd Profit---2233600.000-2108800.000-6%260800.000-956%-760320.000-66%-939624.320-58%
Usd Revenue--7136000.0006612800.000+8%5081600.000+40%4095040.000+74%3118615.200+129%
Usd Total Gains Per Share---0.014-0.014-4%0.004-484%-0.005-65%0.031-145%
 EOD+3 -5MRQTTM+13 -21YOY+10 -245Y+10 -2410Y+13 -21

3.2. Fundamental Score

Let's check the fundamental score of Cyberdyne Inc ADR based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-29.066
Price to Book Ratio (EOD)Between0-10.990
Net Profit Margin (MRQ)Greater than0-0.313
Operating Margin (MRQ)Greater than0-0.301
Quick Ratio (MRQ)Greater than117.197
Current Ratio (MRQ)Greater than118.355
Debt to Asset Ratio (MRQ)Less than10.186
Debt to Equity Ratio (MRQ)Less than10.227
Return on Equity (MRQ)Greater than0.15-0.008
Return on Assets (MRQ)Greater than0.05-0.007
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Cyberdyne Inc ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5036.570
Ma 20Greater thanMa 501.252
Ma 50Greater thanMa 1001.302
Ma 100Greater thanMa 2001.364
OpenGreater thanClose1.230
Total0/5 (0.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Total Other Income Expense Net 2941,8622,1574,7366,893-6,502390-723-333



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in JPY. All numbers in thousands.

Summary
Total Assets50,340,000
Total Liabilities9,343,000
Total Stockholder Equity41,209,000
 As reported
Total Liabilities 9,343,000
Total Stockholder Equity+ 41,209,000
Total Assets = 50,340,000

Assets

Total Assets50,340,000
Total Current Assets18,428,000
Long-term Assets31,912,000
Total Current Assets
Cash And Cash Equivalents 5,234,000
Short-term Investments 11,504,000
Net Receivables 528,000
Inventory 1,071,000
Total Current Assets  (as reported)18,428,000
Total Current Assets  (calculated)18,337,000
+/- 91,000
Long-term Assets
Property Plant Equipment 14,150,000
Goodwill 2,012,000
Intangible Assets 48,000
Long-term Assets Other 186,000
Long-term Assets  (as reported)31,912,000
Long-term Assets  (calculated)16,396,000
+/- 15,516,000

Liabilities & Shareholders' Equity

Total Current Liabilities1,004,000
Long-term Liabilities8,339,000
Total Stockholder Equity41,209,000
Total Current Liabilities
Short-term Debt 232,000
Short Long Term Debt 84,000
Accounts payable 493,000
Other Current Liabilities 279,000
Total Current Liabilities  (as reported)1,004,000
Total Current Liabilities  (calculated)1,088,000
+/- 84,000
Long-term Liabilities
Long term Debt 25,000
Capital Lease Obligations 517,000
Long-term Liabilities Other 5,791,000
Long-term Liabilities  (as reported)8,339,000
Long-term Liabilities  (calculated)6,333,000
+/- 2,006,000
Total Stockholder Equity
Common Stock10,000
Retained Earnings 430,000
Accumulated Other Comprehensive Income -852,000
Other Stockholders Equity 41,621,000
Total Stockholder Equity (as reported)41,209,000
Total Stockholder Equity (calculated)41,209,000
+/-0
Other
Capital Stock10,000
Cash and Short Term Investments 5,234,000
Common Stock Shares Outstanding 211,131
Liabilities and Stockholders Equity 50,340,000
Net Debt -4,608,000
Net Invested Capital 41,318,000
Net Working Capital 17,424,000
Property Plant and Equipment Gross 14,150,000
Short Long Term Debt Total 626,000



Balance Sheet

Currency in JPY. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-31
> Total Assets 
6,434,769
7,255,714
7,210,227
48,514,675
48,289,052
47,983,790
47,987,843
47,808,666
47,534,470
47,232,537
47,085,374
46,964,472
46,848,267
46,560,142
46,337,136
46,402,679
46,598,000
46,372,000
46,650,000
46,342,000
45,745,000
46,114,000
46,666,000
47,467,000
47,808,000
47,453,000
47,986,000
48,076,000
48,119,000
47,792,000
48,460,000
49,232,000
49,459,000
50,583,000
51,407,000
51,166,000
50,187,000
52,282,000
51,000,000
50,340,000
50,340,00051,000,00052,282,00050,187,00051,166,00051,407,00050,583,00049,459,00049,232,00048,460,00047,792,00048,119,00048,076,00047,986,00047,453,00047,808,00047,467,00046,666,00046,114,00045,745,00046,342,00046,650,00046,372,00046,598,00046,402,67946,337,13646,560,14246,848,26746,964,47247,085,37447,232,53747,534,47047,808,66647,987,84347,983,79048,289,05248,514,6757,210,2277,255,7146,434,769
   > Total Current Assets 
5,065,769
5,931,721
5,708,392
43,892,396
43,408,245
42,991,218
41,917,352
41,694,796
41,050,680
35,136,716
35,354,270
34,897,787
34,391,415
32,798,815
31,767,482
32,338,341
31,807,000
31,300,000
31,839,000
31,243,000
30,627,000
30,307,000
30,219,000
30,214,000
29,891,000
28,800,000
28,043,000
28,500,000
27,220,000
26,595,000
24,975,000
23,779,000
22,865,000
21,779,000
21,334,000
21,191,000
19,147,000
19,518,000
18,821,000
18,428,000
18,428,00018,821,00019,518,00019,147,00021,191,00021,334,00021,779,00022,865,00023,779,00024,975,00026,595,00027,220,00028,500,00028,043,00028,800,00029,891,00030,214,00030,219,00030,307,00030,627,00031,243,00031,839,00031,300,00031,807,00032,338,34131,767,48232,798,81534,391,41534,897,78735,354,27035,136,71641,050,68041,694,79641,917,35242,991,21843,408,24543,892,3965,708,3925,931,7215,065,769
       Cash And Cash Equivalents 
4,341,264
5,550,817
5,186,278
43,190,705
29,722,189
29,917,152
29,716,827
19,348,664
14,458,798
10,367,471
10,249,229
10,703,849
10,375,733
8,916,297
8,192,027
7,701,950
10,820,000
10,531,000
10,844,000
22,035,000
8,796,000
11,057,000
10,024,000
10,088,000
9,636,000
8,672,000
7,960,000
8,182,000
6,704,000
6,167,000
5,544,000
7,064,000
5,677,000
6,554,000
6,385,000
6,334,000
7,801,000
8,086,000
8,590,000
5,234,000
5,234,0008,590,0008,086,0007,801,0006,334,0006,385,0006,554,0005,677,0007,064,0005,544,0006,167,0006,704,0008,182,0007,960,0008,672,0009,636,00010,088,00010,024,00011,057,0008,796,00022,035,00010,844,00010,531,00010,820,0007,701,9508,192,0278,916,29710,375,73310,703,84910,249,22910,367,47114,458,79819,348,66429,716,82729,917,15229,722,18943,190,7055,186,2785,550,8174,341,264
       Short-term Investments 
0
0
0
0
12,499,668
12,499,668
11,499,832
21,501,118
25,500,386
24,000,405
24,000,538
23,000,000
23,000,000
23,000,000
22,700,000
23,800,000
20,004,000
20,005,000
20,009,000
8,001,000
20,505,000
18,009,000
19,012,000
19,005,000
19,004,000
19,008,000
19,012,000
19,008,000
19,007,000
19,009,000
18,039,000
15,099,000
15,151,000
13,220,000
13,210,000
13,211,000
9,507,000
9,507,000
8,504,000
11,504,000
11,504,0008,504,0009,507,0009,507,00013,211,00013,210,00013,220,00015,151,00015,099,00018,039,00019,009,00019,007,00019,008,00019,012,00019,008,00019,004,00019,005,00019,012,00018,009,00020,505,0008,001,00020,009,00020,005,00020,004,00023,800,00022,700,00023,000,00023,000,00023,000,00024,000,53824,000,40525,500,38621,501,11811,499,83212,499,66812,499,6680000
       Net Receivables 
464,642
33,271
39,045
72,620
757,515
84,158
159,754
110,491
566,606
101,592
181,589
240,239
372,684
155,144
185,122
177,051
385,000
182,000
260,000
254,000
257,000
195,000
229,000
237,000
263,000
149,000
177,000
214,000
352,000
193,000
256,000
383,000
493,000
433,000
443,000
386,000
540,000
611,000
619,000
528,000
528,000619,000611,000540,000386,000443,000433,000493,000383,000256,000193,000352,000214,000177,000149,000263,000237,000229,000195,000257,000254,000260,000182,000385,000177,051185,122155,144372,684240,239181,589101,592566,606110,491159,75484,158757,51572,62039,04533,271464,642
       Inventory 
199,655
212,813
244,645
291,720
339,208
352,374
328,691
416,705
449,625
553,695
637,743
612,264
526,544
627,440
595,271
615,688
565,000
551,000
656,000
891,000
901,000
917,000
852,000
818,000
832,000
852,000
802,000
823,000
808,000
877,000
990,000
1,089,000
1,089,000
1,117,000
1,071,000
1,071,000
991,000
1,054,000
991,000
1,071,000
1,071,000991,0001,054,000991,0001,071,0001,071,0001,117,0001,089,0001,089,000990,000877,000808,000823,000802,000852,000832,000818,000852,000917,000901,000891,000656,000551,000565,000615,688595,271627,440526,544612,264637,743553,695449,625416,705328,691352,374339,208291,720244,645212,813199,655
       Other Current Assets 
60,208
134,820
238,424
337,351
89,665
137,866
212,248
317,818
75,265
113,553
285,171
341,435
116,454
99,934
95,062
43,652
33,000
31,000
70,000
62,000
168,000
129,000
102,000
66,000
156,000
119,000
92,000
273,000
349,000
349,000
146,000
144,000
455,000
455,000
225,000
189,000
308,000
260,000
117,000
11,595,000
11,595,000117,000260,000308,000189,000225,000455,000455,000144,000146,000349,000349,000273,00092,000119,000156,00066,000102,000129,000168,00062,00070,00031,00033,00043,65295,06299,934116,454341,435285,171113,55375,265317,818212,248137,86689,665337,351238,424134,82060,208
   > Long-term Assets 
1,368,997
1,323,991
1,501,833
4,622,279
4,880,806
4,992,571
6,070,488
6,113,868
6,483,788
12,095,820
11,731,101
12,066,682
12,456,850
13,761,325
14,569,652
14,064,335
14,791,000
15,072,000
14,811,000
15,098,000
15,118,000
15,807,000
16,448,000
17,254,000
17,917,000
18,653,000
19,943,000
19,576,000
20,898,000
21,197,000
23,485,000
25,452,000
26,594,000
28,804,000
30,073,000
29,975,000
31,040,000
32,764,000
32,179,000
31,912,000
31,912,00032,179,00032,764,00031,040,00029,975,00030,073,00028,804,00026,594,00025,452,00023,485,00021,197,00020,898,00019,576,00019,943,00018,653,00017,917,00017,254,00016,448,00015,807,00015,118,00015,098,00014,811,00015,072,00014,791,00014,064,33514,569,65213,761,32512,456,85012,066,68211,731,10112,095,8206,483,7886,113,8686,070,4884,992,5714,880,8064,622,2791,501,8331,323,9911,368,997
       Property Plant Equipment 
1,125,347
1,102,700
1,273,789
4,173,417
4,327,931
4,431,916
4,909,536
4,958,068
5,332,211
10,946,802
10,527,907
10,555,709
10,865,595
10,976,218
11,254,959
11,172,240
11,740,000
11,713,000
11,725,000
11,693,000
12,087,000
12,403,000
12,364,000
12,417,000
12,395,000
12,296,000
12,264,000
12,298,000
13,018,000
12,992,000
13,602,000
13,747,000
14,345,000
14,349,000
14,375,000
14,312,000
14,382,000
14,323,000
14,234,000
14,150,000
14,150,00014,234,00014,323,00014,382,00014,312,00014,375,00014,349,00014,345,00013,747,00013,602,00012,992,00013,018,00012,298,00012,264,00012,296,00012,395,00012,417,00012,364,00012,403,00012,087,00011,693,00011,725,00011,713,00011,740,00011,172,24011,254,95910,976,21810,865,59510,555,70910,527,90710,946,8025,332,2114,958,0684,909,5364,431,9164,327,9314,173,4171,273,7891,102,7001,125,347
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
57,000
57,000
57,000
57,000
57,000
57,000
734,000
2,018,000
2,104,000
2,266,000
2,344,000
2,207,000
2,531,000
2,694,000
2,102,000
2,012,000
2,012,0002,102,0002,694,0002,531,0002,207,0002,344,0002,266,0002,104,0002,018,000734,00057,00057,00057,00057,00057,00057,000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
1,447,000
1,525,000
2,721,000
3,214,000
2,795,000
2,961,000
3,276,000
3,009,000
3,334,000
2,961,000
3,339,000
4,023,000
4,780,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000004,780,0004,023,0003,339,0002,961,0003,334,0003,009,0003,276,0002,961,0002,795,0003,214,0002,721,0001,525,0001,447,00000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
63,000
66,000
63,000
100,000
96,000
90,000
84,000
78,000
71,000
70,000
64,000
61,000
55,000
53,000
50,000
45,000
42,000
38,000
33,000
38,000
37,000
35,000
29,000
59,000
52,000
80,000
76,000
53,000
48,000
48,00053,00076,00080,00052,00059,00029,00035,00037,00038,00033,00038,00042,00045,00050,00053,00055,00061,00064,00070,00071,00078,00084,00090,00096,000100,00063,00066,00063,00000000000000
       Long-term Assets Other 
192,896
185,690
185,846
397,297
179,814
179,122
176,139
173,165
171,089
169,575
167,407
165,927
164,391
156,898
645,629
625,145
81,000
79,000
77,000
76,000
74,000
74,000
71,000
71,000
68,000
66,000
64,000
63,000
60,000
59,000
1,000
55,000
104,000
113,000
121,000
157,000
166,000
228,000
236,000
186,000
186,000236,000228,000166,000157,000121,000113,000104,00055,0001,00059,00060,00063,00064,00066,00068,00071,00071,00074,00074,00076,00077,00079,00081,000625,145645,629156,898164,391165,927167,407169,575171,089173,165176,139179,122179,814397,297185,846185,690192,896
> Total Liabilities 
438,940
412,848
553,221
20,540,537
20,511,754
20,477,095
20,594,052
20,609,961
20,470,536
548,242
589,683
623,133
622,120
601,639
558,805
677,180
924,000
793,000
1,418,000
1,325,000
1,543,000
1,755,000
2,382,000
3,080,000
3,549,000
3,333,000
3,573,000
4,124,000
4,333,000
4,279,000
5,105,000
5,959,000
6,002,000
6,730,000
7,478,000
7,576,000
8,204,000
9,912,000
9,541,000
9,343,000
9,343,0009,541,0009,912,0008,204,0007,576,0007,478,0006,730,0006,002,0005,959,0005,105,0004,279,0004,333,0004,124,0003,573,0003,333,0003,549,0003,080,0002,382,0001,755,0001,543,0001,325,0001,418,000793,000924,000677,180558,805601,639622,120623,133589,683548,24220,470,53620,609,96120,594,05220,477,09520,511,75420,540,537553,221412,848438,940
   > Total Current Liabilities 
274,956
254,095
399,740
490,109
457,167
417,009
528,512
539,015
20,322,560
405,801
452,822
491,903
492,444
476,488
438,185
557,957
659,000
485,000
486,000
386,000
654,000
466,000
385,000
346,000
810,000
518,000
489,000
493,000
635,000
608,000
750,000
861,000
828,000
795,000
791,000
926,000
1,291,000
1,197,000
1,100,000
1,004,000
1,004,0001,100,0001,197,0001,291,000926,000791,000795,000828,000861,000750,000608,000635,000493,000489,000518,000810,000346,000385,000466,000654,000386,000486,000485,000659,000557,957438,185476,488492,444491,903452,822405,80120,322,560539,015528,512417,009457,167490,109399,740254,095274,956
       Short-term Debt 
0
0
0
0
0
0
0
0
19,927,483
0
0
0
0
0
0
0
0
0
0
0
0
42,000
42,000
42,000
98,000
99,000
90,000
90,000
92,000
92,000
97,000
141,000
152,000
167,000
176,000
155,000
236,000
247,000
243,000
232,000
232,000243,000247,000236,000155,000176,000167,000152,000141,00097,00092,00092,00090,00090,00099,00098,00042,00042,00042,00000000000000019,927,48300000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
37,000
37,000
31,000
31,000
31,000
31,000
31,000
31,000
34,000
41,000
34,000
29,000
89,000
93,000
89,000
84,000
84,00089,00093,00089,00029,00034,00041,00034,00031,00031,00031,00031,00031,00031,00037,00037,000000000000000000000000000
       Accounts payable 
26,210
24,061
99,660
44,089
92,195
67,754
62,423
100,013
48,120
48,676
57,258
40,096
20,758
94,036
26,141
23,183
274,000
226,000
292,000
235,000
284,000
204,000
148,000
182,000
247,000
161,000
157,000
185,000
268,000
247,000
346,000
372,000
300,000
377,000
342,000
437,000
690,000
630,000
507,000
493,000
493,000507,000630,000690,000437,000342,000377,000300,000372,000346,000247,000268,000185,000157,000161,000247,000182,000148,000204,000284,000235,000292,000226,000274,00023,18326,14194,03620,75840,09657,25848,67648,120100,01362,42367,75492,19544,08999,66024,06126,210
       Other Current Liabilities 
248,746
230,034
300,080
446,020
364,972
349,255
466,089
439,002
283,153
357,125
395,564
451,807
471,686
382,452
412,044
534,774
385,000
259,000
194,000
151,000
370,000
220,000
195,000
122,000
465,000
258,000
242,000
218,000
275,000
269,000
307,000
348,000
376,000
251,000
273,000
334,000
365,000
320,000
350,000
279,000
279,000350,000320,000365,000334,000273,000251,000376,000348,000307,000269,000275,000218,000242,000258,000465,000122,000195,000220,000370,000151,000194,000259,000385,000534,774412,044382,452471,686451,807395,564357,125283,153439,002466,089349,255364,972446,020300,080230,034248,746
   > Long-term Liabilities 
163,984
158,753
153,481
20,050,428
20,054,587
20,060,086
20,065,540
20,070,946
147,976
142,441
136,861
131,230
129,676
125,151
120,620
119,223
265,000
308,000
932,000
939,000
889,000
1,289,000
1,997,000
2,734,000
2,739,000
2,815,000
3,084,000
3,631,000
3,698,000
3,671,000
4,355,000
5,098,000
5,174,000
5,935,000
6,687,000
6,650,000
6,913,000
8,715,000
8,441,000
8,339,000
8,339,0008,441,0008,715,0006,913,0006,650,0006,687,0005,935,0005,174,0005,098,0004,355,0003,671,0003,698,0003,631,0003,084,0002,815,0002,739,0002,734,0001,997,0001,289,000889,000939,000932,000308,000265,000119,223120,620125,151129,676131,230136,861142,441147,97620,070,94620,065,54020,060,08620,054,58720,050,428153,481158,753163,984
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
134,000
131,000
127,000
122,000
120,000
265,000
308,000
932,000
939,000
890,000
968,000
1,687,000
2,433,000
2,375,000
2,497,000
2,769,000
3,334,000
3,369,000
3,362,000
4,048,000
4,653,000
4,751,000
5,515,000
6,250,000
6,267,000
0
8,282,000
0
0
008,282,00006,267,0006,250,0005,515,0004,751,0004,653,0004,048,0003,362,0003,369,0003,334,0002,769,0002,497,0002,375,0002,433,0001,687,000968,000890,000939,000932,000308,000265,000120,000122,000127,000131,000134,00000000000000
> Total Stockholder Equity
5,995,829
6,842,866
6,657,006
27,972,735
27,774,664
27,506,695
27,393,791
27,198,705
27,063,934
46,684,295
46,495,691
46,341,339
46,226,147
45,958,503
45,778,331
45,721,499
45,698,000
45,604,000
45,243,000
45,033,000
44,217,000
44,375,000
44,298,000
44,399,000
44,268,000
44,139,000
44,436,000
43,977,000
43,776,000
43,509,000
43,352,000
43,205,000
43,419,000
43,816,000
43,906,000
43,600,000
42,101,000
42,513,000
41,647,000
41,209,000
41,209,00041,647,00042,513,00042,101,00043,600,00043,906,00043,816,00043,419,00043,205,00043,352,00043,509,00043,776,00043,977,00044,436,00044,139,00044,268,00044,399,00044,298,00044,375,00044,217,00045,033,00045,243,00045,604,00045,698,00045,721,49945,778,33145,958,50346,226,14746,341,33946,495,69146,684,29527,063,93427,198,70527,393,79127,506,69527,774,66427,972,7356,657,0066,842,8665,995,829
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
26,743,000
26,743,000
26,743,000
26,743,000
26,743,000
26,744,000
26,744,000
26,744,000
26,744,000
26,745,000
26,747,000
26,749,000
26,751,000
26,753,000
26,755,000
26,757,000
26,759,000
10,000
10,000
10,000
10,000
10,000
10,000
10,000
10,000
10,000
10,000
10,000
10,000
10,00010,00010,00010,00010,00010,00010,00010,00010,00010,00010,00010,00026,759,00026,757,00026,755,00026,753,00026,751,00026,749,00026,747,00026,745,00026,744,00026,744,00026,744,00026,744,00026,743,00026,743,00026,743,00026,743,00026,743,00000000000000
   Retained Earnings 
-4,799,064
-4,987,224
-5,173,026
-5,517,956
-5,714,957
-5,982,952
-6,102,161
-6,297,697
-6,433,015
-6,758,056
-6,947,619
-7,095,598
-7,222,347
-7,484,369
-7,668,730
-7,724,495
-7,476,000
-7,671,000
-7,712,000
-7,549,000
-7,972,000
-7,817,000
-8,084,000
-7,986,000
-8,124,000
-8,248,000
-7,952,000
-8,038,000
2,177,000
1,901,000
1,750,000
1,591,000
1,685,000
1,929,000
1,947,000
1,747,000
1,381,000
1,712,000
779,000
430,000
430,000779,0001,712,0001,381,0001,747,0001,947,0001,929,0001,685,0001,591,0001,750,0001,901,0002,177,000-8,038,000-7,952,000-8,248,000-8,124,000-7,986,000-8,084,000-7,817,000-7,972,000-7,549,000-7,712,000-7,671,000-7,476,000-7,724,495-7,668,730-7,484,369-7,222,347-7,095,598-6,947,619-6,758,056-6,433,015-6,297,697-6,102,161-5,982,952-5,714,957-5,517,956-5,173,026-4,987,224-4,799,064
   Capital Surplus 0000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000
   Other Stockholders Equity 
10,794,893
11,830,090
11,830,032
33,490,691
33,489,621
33,489,647
33,495,952
33,496,402
33,496,949
53,442,351
53,443,310
53,436,937
53,448,494
53,442,872
53,447,061
53,445,994
26,430,000
26,531,000
26,211,000
25,838,000
25,444,000
25,445,000
25,633,000
25,634,000
25,639,000
25,632,000
25,631,000
25,256,000
41,589,000
41,598,000
-1,760,000
-1,601,000
-1,695,000
-1,939,000
41,949,000
41,843,000
40,710,000
-1,722,000
40,858,000
41,621,000
41,621,00040,858,000-1,722,00040,710,00041,843,00041,949,000-1,939,000-1,695,000-1,601,000-1,760,00041,598,00041,589,00025,256,00025,631,00025,632,00025,639,00025,634,00025,633,00025,445,00025,444,00025,838,00026,211,00026,531,00026,430,00053,445,99453,447,06153,442,87253,448,49453,436,93753,443,31053,442,35133,496,94933,496,40233,495,95233,489,64733,489,62133,490,69111,830,03211,830,09010,794,893



Balance Sheet

Currency in JPY. All numbers in thousands.




Cash Flow

Currency in JPY. All numbers in thousands.




Income Statement

Currency in JPY. All numbers in thousands.